The technology behind the three shots differs.
READ MORE: Midlothian Police Say Missy Bevers Murder Not A ‘Cold Case’ 5 Years Later
“And that’s what we’ll be doing until the situation resolves,” said Dr. Philip Huang, Director of Dallas County Health and Human Services.
It was welcome news for many of the people who got their shot.
“The Johnson & Johnson vaccine, I was very skeptical,” said Rati Adhikari, who lives in Irving. “So I had made up my mind if there was a change in the vaccine, I would just leave and I’d rather not get vaccinated with Johnson & Johnson.”
Federal officials are looking into a rare blood clotting issue with the Johnson & Johnson vaccine.
It’s similar to what’s been reported in Europe with AstraZeneca’s vaccine, which hasn’t been authorized for use in the U.S. yet.
READ MORE: ERCOT Sends Alert About Possible ‘Emergency Conditions’, Calls On Texans To Conserve
“I think this was done appropriately,” said Crystal Howell, an assistant professor of pharmacotherapy at the UNT Health Science Center. “They’re looking at Europe’s data for a similar type of technology. They found six patients here, they said that’s enough, we’re going to investigate.”
Both the Johnson & Johnson and the AstraZeneca are adenovirus vaccines, which means they use a shell of a virus as a vector to carry genetic material into your cells.
Clotting problems haven’t been seen with either of the two vaccines.
According to the Texas Department of State Health Services, 13 million Moderna and Pfizer vaccines have been administered in Texas, along with approximately 560,000 doses of the Johnson & Johnson vaccine.
MORE NEWS: J&J COVID-19 Vaccine Probe Fueling New Hesitancy In Dallas’ Minority Community
Of those, not a single dose has resulted in a reported case of blood clotting within Texas.
[Moderna Stock – Dallas County Gives Moderna And Pfizer COVID-19 Vaccines At Fair Park, With J&J On Pause – CBS Dallas / Fort Worth
Tags: Moderna Stock, NASDAQ: MRNA
Stock Market, Latest News on C N N.